Arash Navran

983 total citations
46 papers, 646 citations indexed

About

Arash Navran is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Arash Navran has authored 46 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Otorhinolaryngology, 22 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Arash Navran's work include Head and Neck Cancer Studies (36 papers), Head and Neck Surgical Oncology (11 papers) and Advanced Radiotherapy Techniques (9 papers). Arash Navran is often cited by papers focused on Head and Neck Cancer Studies (36 papers), Head and Neck Surgical Oncology (11 papers) and Advanced Radiotherapy Techniques (9 papers). Arash Navran collaborates with scholars based in Netherlands, Germany and United Kingdom. Arash Navran's co-authors include Abrahim Al‐Mamgani, Olga Hamming‐Vrieze, W. Martin C. Klop, Michiel W. M. van den Brekel, Mischa de Ridder, Jan Paul de Boer, Johannes A. Langendijk, Abrahim Al‐Mamgani, J. Duppen and Edwin R. van den Heuvel and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Arash Navran

44 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arash Navran Netherlands	15	353	217	211	195	193	46	646
Maria Grazia Ruo Redda Italy	15	252 0.7×	297 1.4×	123 0.6×	120 0.6×	149 0.8×	36	672
Laura Marucci Italy	17	231 0.7×	288 1.3×	165 0.8×	276 1.4×	144 0.7×	46	711
Abrahim Al‐Mamgani Netherlands	15	403 1.1×	222 1.0×	93 0.4×	157 0.8×	266 1.4×	38	663
Nader Khaouam Canada	8	300 0.8×	241 1.1×	64 0.3×	434 2.2×	131 0.7×	10	697
Tim Dijkema Netherlands	16	406 1.2×	343 1.6×	302 1.4×	244 1.3×	211 1.1×	33	732
Mehmet Şen United Kingdom	21	701 2.0×	345 1.6×	145 0.7×	221 1.1×	382 2.0×	53	1000
Henk P. Bijl Netherlands	13	449 1.3×	357 1.6×	363 1.7×	345 1.8×	167 0.9×	16	770
Jennifer Shah United States	12	280 0.8×	169 0.8×	36 0.2×	173 0.9×	178 0.9×	48	557
Zubin Master Singapore	11	247 0.7×	360 1.7×	301 1.4×	278 1.4×	191 1.0×	41	666
Sonja Stieb Switzerland	15	119 0.3×	265 1.2×	150 0.7×	399 2.0×	101 0.5×	43	650

Countries citing papers authored by Arash Navran

Since Specialization

Citations

This map shows the geographic impact of Arash Navran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Navran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Navran more than expected).

Fields of papers citing papers by Arash Navran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Navran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Navran. The network helps show where Arash Navran may publish in the future.

Co-authorship network of co-authors of Arash Navran

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Navran. A scholar is included among the top collaborators of Arash Navran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Navran. Arash Navran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smit, Laura A., Jan Paul de Boer, Arash Navran, et al.. (2025). [18F]FDG-PET/CT’s change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial. European Journal of Nuclear Medicine and Molecular Imaging. 53(4). 2217–2233.

Vos, Joris L., Joleen J.H. Traets, Xiaohang Qiao, et al.. (2024). Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma. JCI Insight. 9(21). 5 indexed citations

Molen, Lisette van der, et al.. (2024). Lymphedema and Trismus after Head and Neck Cancer, and the Impact on Body Image and Quality of Life. Cancers. 16(3). 653–653. 6 indexed citations

Al‐Mamgani, Abrahim, Rob Kessels, Arash Navran, et al.. (2023). Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study). Clinical and Translational Radiation Oncology. 43. 100676–100676. 3 indexed citations

Navran, Arash, Abrahim Al‐Mamgani, Rob Kessels, et al.. (2023). Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma. Clinical and Translational Radiation Oncology. 44. 100698–100698. 2 indexed citations

Verheij, Marcel, Arash Navran, Abrahim Al‐Mamgani, et al.. (2023). 888P Phase I study of olaparib combined with loco-regional radiotherapy in patients with head and neck squamous cell carcinoma. Annals of Oncology. 34. S569–S569. 1 indexed citations

Roest, Reinout H. de, Frederik Wesseling, Emma J. de Ruiter, et al.. (2022). Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer. Radiotherapy and Oncology. 175. 112–121. 15 indexed citations

Al‐Mamgani, Abrahim, Rob Kessels, Tomas Janssen, et al.. (2022). The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction. Radiotherapy and Oncology. 168. 16–22. 16 indexed citations

Al‐Mamgani, Abrahim, Rob Kessels, Arash Navran, et al.. (2021). Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes. Radiotherapy and Oncology. 162. 170–177. 9 indexed citations

10.

Beek, Suzanne van, Olga Hamming‐Vrieze, Abrahim Al‐Mamgani, et al.. (2019). Protocolised way to cope with anatomical changes in head & neck cancer during the course of radiotherapy. Technical Innovations & Patient Support in Radiation Oncology. 12. 34–40. 18 indexed citations

11.

Ridder, Mischa de, Arash Navran, Olga Hamming‐Vrieze, et al.. (2019). FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation. European Archives of Oto-Rhino-Laryngology. 276(5). 1447–1455. 6 indexed citations

12.

Hamming‐Vrieze, Olga, Arash Navran, Abrahim Al‐Mamgani, & Wouter V. Vogel. (2018). Biological PET-guided adaptive radiotherapy for dose escalation in head and neck cancer: a systematic review. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 62(4). 349–368. 14 indexed citations

13.

Al‐Mamgani, Abrahim, et al.. (2018). Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?. European Archives of Oto-Rhino-Laryngology. 276(2). 575–583. 17 indexed citations

14.

Al‐Mamgani, Abrahim, Mischa de Ridder, Arash Navran, et al.. (2017). The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 274(10). 3757–3765. 41 indexed citations

15.

Jasperse, Bas, Jan‐Jakob Sonke, Wilma D. Heemsbergen, et al.. (2017). A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response. Clinical and Translational Radiation Oncology. 6. 1–6. 5 indexed citations

16.

Al‐Mamgani, Abrahim, Erik van Werkhoven, Arash Navran, et al.. (2017). Contralateral regional recurrence after elective unilateral neck irradiation in oropharyngeal carcinoma: A literature-based critical review. Cancer Treatment Reviews. 59. 102–108. 45 indexed citations

17.

Lohuis, Peter J. F. M., Wilma D. Heemsbergen, Arash Navran, et al.. (2016). Orthovoltage for basal cell carcinoma of the head and neck: Excellent local control and low toxicity profile. The Laryngoscope. 126(8). 1796–1802. 8 indexed citations

18.

Lohuis, Peter J. F. M., Marianne B. Crijns, Arash Navran, et al.. (2016). Orthovoltage X-rays for Postoperative Treatment of Resected Basal Cell Carcinoma in the Head and Neck Area. Journal of Cutaneous Medicine and Surgery. 21(3). 243–249. 8 indexed citations

19.

Ridder, Mischa de, et al.. (2013). The influence of nodal yield in neck dissections on lymph node ratio in head and neck cancer. Oral Oncology. 50(1). 59–64. 50 indexed citations

20.

Brouwer, Charlotte L., Roel J.H.M. Steenbakkers, Edwin R. van den Heuvel, et al.. (2012). 3D Variation in delineation of head and neck organs at risk. Radiation Oncology. 7(1). 32–32. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact